US News

Pfizer-BioNTech Booster 95.6% Effective in Trial, Companies Say

The study was carried out while the highly contagious Delta variant was prevalent, the companies said, suggesting the booster helps protect against the contagious strain.

Jump To The Original Source

Facebook Comments

Check Also

The Struggling Tech Companies

In his Daily Market Notes report to investors, ...

Archives